Odalasvir

Star0

DB13041InvestigationalSmall molecule

Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.

Mechanism: Pharmacologically active on Nonstructural protein 5A
Curator reviewed
Formula / weight: C₆₀H₇₂N₈O₆ · 1001.286 g/mol (avg)
Code names: ACH-0143102 · ACH-3102

Resolves to

Compound

UNIIOVR52K7BDWCAS1415119-52-6ChEMBLCHEMBL3544977PubChem71474517

Structure

InChIKeyLSYBRGMTRKJATA-IVEWBXRVSA-NSMILES

COC(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@H]12)C1=NC2=CC=C(C=C2N1)C1=CC2=CC=C1CCC1=CC=C(CC2)C(=C1)C1=CC=C2N=C(NC2=C1)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@@H](NC(=O)OC)C(C)C

Targets

Q5L478NS5AP26664Genome polyprotein

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Drug interactionsStructured to mechanism, not free text

6Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Odalasvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account